Prostate Cancer

Who might be able to join this trial: - You have been diagnosed with prostate cancer that has spread to the bones - Your PSA (a protein measured in a blood test related to prostate cancer) has been rising over the past month - You have no pain, or only mild pain, caused by your prostate cancer - You are currently havin...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer that has spread to the bones. - Your PSA (a protein measured by a blood test used to monitor prostate cancer) levels have been rising, with a test result taken within the last year. - You are currently being treated to lower testos...

**Who might be able to join this trial:** - You have been tested and confirmed to carry a harmful (or possibly harmful) change in the BRCA1 or BRCA2 gene (a gene mutation linked to cancer risk), confirmed before joining the study - You have a solid tumour (a type of cancer growth) that has been confirmed, and there are...

Who might be able to join this trial: - You have been diagnosed with prostate cancer that has spread (metastatic) and confirmed by a tissue biopsy to be a specific type called adenocarcinoma. - You are currently receiving hormone therapy to lower testosterone (using injections or implants called GnRH analogues) or have...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by a lab test on tissue) - You are male and at least 18 years old - Your prostate cancer has been shown to be getting worse, either through rising PSA blood test results or through...

**Who might be able to join this trial:** - Adults (as defined by local law at the time of signing consent) may be considered. - People who have been diagnosed with a specific type of prostate cancer confirmed by laboratory testing of tissue or cell samples — specifically adenocarcinoma, but not certain rare subtypes...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by lab testing of a tissue or cell sample) - People whose prostate cancer continued to grow or spread while receiving hormone-blocking treatment (or after surgical removal o...

**Who might be able to join this trial:** - People who are reasonably active and able to care for themselves (rated 0 or 1 on a standard activity scale used by doctors) - People with a life expectancy of at least 3 months - People who are able to swallow tablets or capsules - People whose blood counts fall within acce...

**Who might be able to join this trial:** - You are male and have been diagnosed with prostate cancer (specifically a type called adenocarcinoma, confirmed by a tissue test) - Your cancer has a specific type of DNA repair fault called a "homologous recombination defect" (HRD), confirmed by a validated genetic test on...

**Who might be able to join this trial:** *(Note: This trial has multiple parts with different requirements. The trial site will determine which part, if any, a person may be considered for.)* **General requirements that apply to all parts:** - People diagnosed with prostate cancer that has spread to other parts of...

**Who might be able to join this trial:** - People who have been diagnosed with locally advanced or metastatic breast cancer that is oestrogen receptor-positive and HER2-negative (ER+HER2-), castration-resistant prostate cancer, or non-small cell lung cancer that has not responded to or cannot tolerate standard treatm...

Who might be able to join this trial: - You are scheduled to receive radiation therapy for cancer of the brain, breast, head and neck, kidney, liver, pancreas, prostate, or spine — or for a heart rhythm condition — at a participating treatment centre. - You will have a CT planning scan and at least one cone beam CT sca...

Who might be able to join this trial: - People who are willing and able to give their informed consent to participate - People aged 18 or older - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through a tissue or cell sample - People who are currently receivi...

**Who might be able to join this trial:** - The person has given written consent to participate in the trial. - The person is male and aged 18 or older at the time of signing consent. - The person has a confirmed diagnosis of prostate cancer (adenocarcinoma), or a clear diagnosis of prostate cancer that has spread to...

**Who might be able to join this trial:** - Men aged 18 years or older at the time of screening - People who have given written consent to participate in the trial - People who have been diagnosed with prostate cancer (adenocarcinoma type), confirmed through a tissue sample (biopsy) - People who have already had treatm...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer that has spread to other parts of the body (metastatic), confirmed by a tissue biopsy showing a specific type of cancer called adenocarcinoma. - People whose cancer is getting worse, shown by either a significant rise in a...

Who might be able to join this trial: - People who are generally well enough to carry out daily activities with little to no limitation (this is measured using a standard scale called ECOG, where a score of 0 or 1 is required) - People who have been diagnosed with prostate cancer that has spread to other parts of the b...

Who might be able to join this trial: - You have been diagnosed with metastatic prostate cancer that no longer responds to hormone therapy (called castration-resistant prostate cancer, or mCRPC), confirmed by a tissue biopsy, depending on which part of the trial you are being considered for - For some parts of the tria...

Who might be able to join this trial: - People who have prostate cancer that has spread to other parts of the body, confirmed by at least one scan (CT, MRI, or bone scan). - People whose cancer has continued to grow or spread, shown by rising PSA levels on at least two tests taken a week apart, new or growing tumours...

Who might be able to join this trial: - People who have been confirmed through a tissue sample (biopsy) to have a type of prostate cancer called adenocarcinoma. Adenocarcinoma that also has small cell or neuroendocrine features is allowed, but purely small cell carcinoma or certain other rare types are not. - People wh...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, not small cell type), confirmed by a lab test on a tissue or cell sample. - People whose prostate cancer continued to grow or spread while receiving hormone-suppressing treatment (or...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) confirmed through a tissue or cell sample - People whose prostate cancer has continued to grow or spread while receiving hormone-suppressing treatment (androgen deprivation therapy, o...

**Who might be able to join this trial:** - People aged 18 or older at the time of signing the consent form. - People who have a confirmed diagnosis of prostate cancer that has spread to other parts of the body (metastatic), is a specific cell type called adenocarcinoma, and does not have certain aggressive features (...

Who might be able to join this trial: - People who agree to take part and give their consent - People between the ages of 18 and 90 years old - People who have been diagnosed with localised prostate cancer (cancer that has not spread beyond the prostate) - People who are receiving care at a hospital that is partnered w...

**Who might be able to join this trial:** - People who have a confirmed diagnosis of prostate adenocarcinoma (a specific type of prostate cancer), not including a type called small cell. - People whose prostate cancer has gotten worse, and who have had hormone-suppressing treatment (ADT) or surgical removal of the tes...

Who might be able to join this trial: - People who are male and aged 18 years or older at the time of signing consent - People who have a confirmed prostate cancer diagnosis (confirmed through tissue testing) and are scheduled to have their prostate surgically removed within 28 days of the screening visit - People whos...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer that has spread to other parts of the body and is no longer responding to hormone therapy (confirmed by a tissue or cell sample). - People aged 18 years or older. - People who are willing and able to sign a consent form and foll...

**Who might be able to join this trial:** - Adults aged 18 or older - People whose overall health and ability to carry out daily activities is rated at a good level (a score of 0 or 1 on a standard oncology scale) - People whose surgical notes confirm that both nerve bundles alongside the prostate were successfully pr...

**Who might be able to join this trial:** - Men aged 18 or older who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a tissue sample test. - People who are reasonably active and able to care for themselves, and whose doctors estimate they have at least 6 months to li...

Who might be able to join this trial: - People who are over 18 years of age - People who have been diagnosed with prostate cancer confirmed by a biopsy - People whose planned treatment is radiation therapy to the prostate only (no surgery or other treatment) - People who are reasonably active and able to care for thems...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a tissue sample - People who are 18 years of age or older - People who are generally able to carry out daily activities with no or minimal limitations (as assessed...

Who might be able to join this trial: - Adults aged 18 years or older. - People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard medical scoring system called ECOG (scores 0 to 2, meaning fully active to capable of limited self-care). - People who ha...

Who might be able to join this trial: - People with advanced or spreading breast cancer that is ER-positive and HER2-negative, a type of advanced prostate cancer that no longer responds to hormone treatment (mCRPC), or a type of lung cancer called non-small cell lung cancer (NSCLC) — depending on which part of the tri...

**Who might be able to join this trial:** - People who are able to understand what the trial involves, including possible side effects, and who choose to take part voluntarily - People whose bone marrow and other major organs are functioning well enough (as determined by the trial site through testing) - People whose l...

Who might be able to join this trial: - People who have been diagnosed with a type of prostate cancer called adenocarcinoma, confirmed by a tissue or cell sample, that is not the small cell type. - People whose prostate cancer continued to grow or spread while they were on hormone-reducing therapy (or after surgical re...

Who might be able to join this trial: - People who are relatively well and able to carry out daily activities, rated 0 or 1 on a standard health performance scale used in cancer care. - People who have been diagnosed with a specific type of prostate cancer called adenocarcinoma, confirmed by laboratory testing, and wit...

Who might be able to join this trial: - Men aged 18 or older - People who are willing to participate and able to sign a consent form showing they understand what the study involves - People who have previously had their prostate removed (radical prostatectomy) due to a confirmed prostate cancer diagnosis - People whose...

**Who might be able to join this trial:** - You are male and have been diagnosed with prostate cancer (confirmed by a tissue sample/biopsy). - You have either newly diagnosed high-risk prostate cancer (cancer that has not spread far, but is considered aggressive) or your cancer has come back after prostate removal sur...

**Who might be able to join this trial:** - People whose general physical functioning is reasonably well-preserved, rated on a standard medical scale as 0, 1, or 2 out of 4 (meaning able to carry out at least some daily activities) - People who have been diagnosed with prostate cancer confirmed by tissue testing to be...

**Who might be able to join this trial:** - Male participants who are 18 years of age or older at the time of screening (or the minimum age required by local rules). - People whose prostate cancer has been confirmed by a tissue or cell sample as adenocarcinoma (a specific type of prostate cancer), without certain aggr...

**Who might be able to join this trial:** - Men who are at least 18 years old - Men where prostate cancer is suspected by their doctor, and a template biopsy (a type of prostate tissue sampling procedure) has been planned, based on either a recent MRI scan result or non-imaging risk factors (see below) - Men whose rec...

**Who might be able to join this trial:** - People who have been confirmed through lab testing (tissue or cell samples) to have prostate cancer of the adenocarcinoma type — mixed types (such as adenocarcinoma combined with a neuroendocrine component) are not permitted. - People who were diagnosed with prostate cancer...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (specifically adenocarcinoma) confirmed by a tissue sample (biopsy). - People whose prostate cancer has spread to bones or lymph nodes (or both), is no longer responding to hormone-lowering treatment, and has no clear signs of s...

Who might be able to join this trial: - People who are male and have been diagnosed with prostate cancer that has spread to other parts of the body, and whose cancer still responds to hormone treatment (known as metastatic hormone-sensitive prostate cancer) - People who have been dispensed at least one of the following...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed through a tissue sample test - People whose prostate cancer has spread to other parts of the body at the time of screening, as determined by the study doctor - People who a...

Who might be able to join this trial: - Participants must have signed a consent form before taking part in the study. - Participants must be adults aged 18 or older. - Participants must have a reasonable level of physical functioning, rated on a standard medical scale from 0 (fully active) to 2 (able to care for onesel...

**Who might be able to join this trial:** - People who are willing and able to give informed consent before any study procedures begin, and who are willing to follow all study requirements. - Men aged 18 or older. - People who have a confirmed diagnosis of prostate cancer that has either spread to other parts of the b...

Who might be able to join this trial: - People whose general health and ability to carry out daily activities is rated at a good level (scored 0 or 1 on a standard health scale), with no worsening in the 2 weeks before starting the trial - People whose organs (such as kidneys and liver) are functioning adequately - Peo...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (specifically adenocarcinoma) confirmed by a laboratory tissue or cell test, without certain aggressive subtypes called small-cell or neuroendocrine features - People whose prostate cancer has spread to other parts of the b...

Who might be able to join this trial: - People who have been confirmed through a tissue sample (biopsy) to have prostate cancer, either the common gland-cell type (adenocarcinoma) or a less common type involving nerve-like cells (neuroendocrine differentiated prostate cancer). - People whose testosterone has been reduc...

Who might be able to join this trial: - Men who have high-risk prostate cancer that has come back (shown by rising PSA levels after treatment) and have not yet had hormone-blocking therapy, with or without additional hormone-targeting drugs - Men who have already had hormone-blocking therapy, with or without additional...

**Who might be able to join this trial:** - People who are generally well enough to carry out light activity and care for themselves (a measure called ECOG Performance Status of 0 or 1) - People with a life expectancy of at least 3 months - People whose prostate cancer has been confirmed by a tissue or cell sample (bio...

Who might be able to join this trial: - People whose overall health and ability to carry out daily activities meets a certain minimum level, as measured by a standard oncology scoring system (confirm with trial site) - People who have had their prostate cancer confirmed by a tissue or cell sample as a type called adeno...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer that has been confirmed by a tissue sample as a specific type called adenocarcinoma (not rare types like small cell, neuroendocrine, or others) - Doctors expect you to live for at least 3 months or more - You are generally able to...

**Who might be able to join this trial:** - You are 18 years of age or older - You have a confirmed diagnosis of advanced or metastatic breast cancer or prostate cancer (confirmed by a tissue or cell sample test) - You are generally well enough to carry out light activity and care for yourself (your doctor will assess...

Who might be able to join this trial: - People who are 18 years of age or older and have a known or suspected cancer, as well as healthy volunteers in the same age range. - People whose physical functioning falls within a certain range, rated on a standard medical scale from fully active (0) to limited self-care (3) —...

Who might be able to join this trial: - You have previously received a vaccine or immune-based treatment (such as poxviral vaccines or other gene-based therapies) as part of a cancer research study at the National Cancer Institute or a linked research site. - You are 18 years of age or older. Who may not be able to jo...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer through a biopsy, where the laboratory confirmed it is a specific type called adenocarcinoma. - People whose prostate cancer appears to be contained within or near the prostate and has not spread to nearby lymph nodes or ot...

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with prostate cancer Who may not be able to join: - Children and anyone under the age of 18 Important: Always verify eligibility with the trial site directly before applying.

Who might be able to join this trial: - You have prostate cancer that was treated mainly with surgery to remove the prostate (whether done through open surgery, keyhole surgery, or robot-assisted surgery). - Your PSA level (a blood marker for prostate cancer) was no higher than 20 ng/ml. Who may not be able to join: -...

**Who might be able to join this trial:** - People diagnosed with bladder, urothelial, or prostate cancer — whether the cancer is confined to the original organ or has spread — where a tissue sample can be taken from the primary site, a bone deposit, or a soft tissue deposit with low risk of complications - People wit...

**Who might be able to join this trial:** - People who have been confirmed to have prostate cancer through a tissue sample (biopsy) taken via the rectum or through a template procedure - People whose biopsy results (from standard ultrasound-guided, MRI-targeted, or template biopsy) meet specific findings about how muc...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy) - People who are part of a family with a known history of hereditary prostate cancer - Healthy men who do not have prostate cancer (as a comparison group) Who may not be able to join: - Peo...

Who might be able to join this trial: - People who are currently enrolled in a clinical trial within the NIH's internal (intramural) research program and are receiving treatment as part of that trial. - People aged 3 years or older. - People who are able to understand and agree to sign a consent form, or who have a leg...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (confirmed by a tissue sample taken within the past year) that is considered "intermediate risk" based on at least one of the following: a Gleason score of 7, a PSA level between 10 and 20, or a tumour stage of T2b–T2c. - Your can...

**Who might be able to join this trial:** - Your prostate cancer has come back locally (confirmed by biopsy) without spreading to other parts of the body, after you previously received hormone therapy and radiation treatment that finished at least 2 years ago - You are generally active and able to carry out daily activ...

Who might be able to join this trial: - You must be male - You must be 18 years of age or older - You must have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by a tissue test) - Your prostate cancer must not have spread to other parts of the body - You must be planning to have yo...

Who might be able to join this trial: - You have been diagnosed with prostate cancer confirmed through a tissue sample (biopsy). - You have had a biopsy within the last 12 months before signing up, unless your cancer already qualifies you for the higher-risk group in this study (confirm with trial site for details on w...

**Who might be able to join this trial:** - People who have had a radical prostatectomy (surgical removal of the prostate) for confirmed prostate cancer - People whose cancer was confirmed by a pathologist to be at stage T1, T2, or T3 (meaning the cancer was contained or had only limited spread beyond the prostate) -...

**Who might be able to join this trial:** - People aged 75 or younger at the time of joining the trial - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma) confirmed by a tissue sample, who have not yet received any treatment for it - People whose overall health and mental...

**Who might be able to join this trial:** - Men between 55 and 65 years old who have been diagnosed with low or intermediate risk prostate cancer, where fewer than half of the tissue samples taken from either side of the prostate tested positive for cancer - Men older than 65 years old who have been diagnosed with pro...

**Who might be able to join this trial:** - People who are over 18 years old - People who have been diagnosed with prostate cancer confirmed through a tissue sample (biopsy) - People whose cancer has a Gleason Score (a measure of how aggressive the cancer looks under a microscope) of 6 or lower (specifically scored as...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (a type called adenocarcinoma) confirmed by a tissue sample (biopsy), which may have been done at another hospital as long as detailed results are available. - For Group A only: People who are scheduled to have their prostate su...

**Who might be able to join this trial:** - Men of any ethnicity who have a close family history of prostate cancer — for example, a father, brother, or son diagnosed with prostate cancer before age 70; or two relatives on the same side of the family with prostate cancer where at least one was diagnosed before age 70;...

Who might be able to join this trial: - People with prostate cancer that has grown beyond the outer layer of the prostate (known as T3a or more advanced stage) - People whose PSA level (a protein measured in the blood related to prostate health) is above 20 - People whose cancer has been graded as a Gleason score of 8...

**Who might be able to join this trial:** - Adults aged 18 or older who have been diagnosed with prostate cancer (confirmed by biopsy) or are suspected of having prostate cancer, and who need and are willing to undergo a diagnostic procedure, treatment, or follow-up monitoring as part of their care - People who are re...

**Who might be able to join this trial:** - People diagnosed with early-stage prostate cancer, based on their medical records, with specific cancer severity and grade scores within certain ranges (confirm with trial site for exact values) - People who have had their prostate surgically removed (called a radical prosta...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy) - People whose cancer is considered suitable for treatment aimed at curing the disease - People who are reasonably active and able to carry out daily activities (rated on a standard health s...

"Who might be able to join this trial: - People who have been diagnosed with prostate cancer Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Important: Always verify eligibility with the trial site directly before applying."

Who might be able to join this trial: - People who are scheduled to have their first-ever prostate biopsy (a procedure to check for cancer) - People who have a higher-than-normal PSA blood test result (above 4 ng/ml) and/or an abnormal result from a physical examination of the prostate Who may not be able to join: - P...

Who might be able to join this trial: - Men under 80 years of age - People who have been diagnosed with a specific type of prostate cancer (adenocarcinoma) confirmed through a biopsy that took at least 10 tissue samples - People whose PSA blood test result before biopsy was 10 ng/ml or lower - People whose PSA density...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a tissue test (biopsy or lab analysis). - People at any stage of prostate cancer, including those whose cancer has spread to lymph nodes or other parts of the body — in fact, patients with spread (metastatic) diseas...

Who might be able to join this trial: - People who have been treated for prostate cancer with the goal of curing it, and whose cancer had spread to nearby lymph nodes - People who will be receiving radiation therapy as part of their treatment, including after surgery or as an additional (adjuvant) treatment - People wh...

**Who might be able to join this trial:** - People who are willing to sign a consent form and follow the treatment and follow-up schedule - People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy or surgery) - People who have not received any previous treatment for prostate cancer - Peo...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma), confirmed through a tissue sample examination. - People aged between 30 and 100 years old. - People who agree to undergo at least one of the following treatments for their prostate ca...

**Who might be able to join this trial:** - People who are planning to have a prostate biopsy, or who have already had one within the past 6 weeks - Men between the ages of 30 and 100 - People who have previously been diagnosed with prostate cancer and are having a repeat biopsy, where testosterone levels are within t...

Who might be able to join this trial: - People aged between 40 and 75 years old who have been diagnosed with prostate cancer confirmed by a tissue biopsy. - People whose major organs (such as the heart, liver, and kidneys) are functioning without severe problems. - People who are generally able to carry out daily activ...

**Who might be able to join this trial:** - People who have given written consent to participate before any trial procedures begin - People who have been confirmed through a tissue sample (biopsy) to have prostate adenocarcinoma (a specific type of prostate cancer), without small cell features - People whose cancer st...

Who might be able to join this trial: - People who have had a prostate biopsy reviewed by pathology (laboratory specialists) at one of these locations: Emory University, Grady Memorial Hospital, Saint Joseph's Hospital, or Atlanta VA Medical Center, and whose prostate cancer has been classified as an early stage (stage...

**Who might be able to join this trial:** **Group 1 (patients planning surgery):** - You are under 75 years old and have been diagnosed with prostate cancer confirmed by a tissue biopsy (specifically a type called invasive adenocarcinoma) - Your cancer is considered intermediate to high risk, with at least a 5% chance...

Who might be able to join this trial: - People who are at higher-than-average risk of prostate cancer due to a strong family history of the disease and/or an inherited genetic mutation affecting DNA repair. - People who have already been diagnosed with prostate cancer, or who have lesions (abnormal areas) that are cons...

**Who might be able to join this trial:** - Adults aged 18 or older - People with a confirmed tissue diagnosis of prostate adenocarcinoma (a specific type of prostate cancer) at various stages, for whom treatment has been recommended - People who are willing and able to provide written consent to participate - *(For o...

**Who might be able to join this trial:** - You have been diagnosed with early-stage prostate cancer, confirmed through a tissue or cell sample test. - Your cancer is classified as either "low-risk" or "favorable intermediate-risk" based on specific test results, including your PSA level, Gleason score, and biopsy resu...

**Who might be able to join this trial:** - You must have previously taken part in a specific earlier study called "VANDAAM" (study MCC#18523) - Your genetic test result from that earlier study (called a Decipher score) must have come back as high-risk, meaning a score above 0.45 - You must have had your genetic test s...

**Who might be able to join this trial:** - Men between 40 and 80 years of age - People who have been diagnosed with low- to intermediate-risk prostate cancer, confirmed by tissue testing, with a Gleason score of 7 or less and a primary grade of 4 or less - People whose prostate cancer is at a clinical stage of T1c or...

Who might be able to join this trial: - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a laboratory test on a tissue or cell sample - People who still have their prostate intact, with no prior treatments aimed at the prostate cancer itself (though previou...

**Who might be able to join this trial:** - Male patients who have prostate cancer that has not spread beyond the prostate (stages cT1c–T2c) and are planning to have a nerve-sparing robotic prostate removal surgery - People whose prostate-specific antigen (PSA) blood test result was below 15 ng/ml in the last 12 month...

**Who might be able to join this trial:** - People who are willing and able to sign a written consent form for the trial - People who are able to understand and follow the trial's rules and procedures - People who are 18 years of age or older at the time of signing the consent form - People whose cancer can be measure...

Who might be able to join this trial: - Men who are suspected of having prostate cancer but have not yet been diagnosed - Men who are already scheduled for, or are due to be scheduled for, a prostate biopsy as part of their normal medical care Who may not be able to join: - Men from whom blood and urine samples cannot...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed by a tissue or cell sample. - You are currently on, or have previously been on, an "active surveillance" plan (a watchful waiting approach instead of immediate treatment) managed a...

Who might be able to join this trial: - People who are 18 years of age or older - People who have bothersome urinary symptoms, measured by a standard symptom score of 15 or higher, and/or have a large amount of urine remaining in the bladder after urinating (350mL or more), and/or rely on a catheter to empty their blad...

Who might be able to join this trial: - Men between the ages of 30 and 75 years old - People who have a confirmed harmful or likely harmful genetic variant in a prostate cancer risk-related gene, identified by a certified laboratory — this includes variants in genes such as BRCA1, BRCA2, Lynch syndrome-related genes (M...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (confirmed by a tissue sample) where curative local treatment is no longer considered possible. - People aged 18 or older with a life expectancy of at least 6 months. - People whose prostate cancer has continued to grow or...

Who might be able to join this trial: - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a laboratory tissue test — not the small cell or neuroendocrine types. - People whose surgeon has determined they are a suitable candidate for prostate removal surgery (...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed by a laboratory test. - People who had a biopsy with at least 10 tissue samples taken, with each sample examined separately to identify exactly where the cancer is located....

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a biopsy - People whose prostate cancer is classified as "low risk" based on a standard medical scoring system called d'Amico — meaning the cancer is at an early sta...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a type called adenocarcinoma) confirmed by a tissue or cell sample, with cancer that has spread to other parts of the body (such as bones or soft tissue). - People who have had scans to assess all areas of disease (includi...

Who might be able to join this trial: - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) - People whose general health and ability to carry out daily activities meets a certain standard (confirm with trial site) - People whose cancer is at an early clinical stage, with no...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed by a biopsy, at any stage or grade - People who have been prescribed or are already receiving continuous hormone therapy (to reduce testosterone) for less than 5 years - Pe...

**Who might be able to join this trial:** - You are a man who has been diagnosed with prostate cancer (confirmed by a tissue sample) that has spread to other parts of the body, and you are starting your first main treatment for this advanced stage - Your cancer has been found to have spread (to bones or other areas) t...

**Who might be able to join this trial:** - You have been diagnosed with prostate, rectal, or head and neck cancer (confirmed by a tissue or cell sample), have not yet received any first-line treatment, and are planned to receive radiation therapy. - Your cancer can be measured by ultrasound or MRI scan done within 28...

Who might be able to join this trial: - Men aged 18 years or older - People with a PSA (prostate-specific antigen) blood test result above 4 ng/ml, which is considered higher than normal - People who are already scheduled to have a prostate biopsy (a procedure to take a small tissue sample from the prostate) Who may n...

Who might be able to join this trial: - People who have been diagnosed with intermediate- or high-risk prostate cancer, confirmed by a laboratory test on tissue samples. - People whose PSA levels have risen on more than one test to above 0.2 ng/mL but no higher than 1.0 ng/mL after having their prostate surgically remo...

**Who might be able to join this trial:** *For men with advanced prostate cancer (mCRPC):* - Men who have been diagnosed with a specific type of prostate cancer (adenocarcinoma) confirmed by lab testing, but not the pure small cell type. - Men whose PSA level is at least 4 ng/mL at the screening visit and has been ris...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a tissue sample - People with an early-stage prostate cancer (T1–T2b based on a specific staging system) with a cancer aggressiveness score (Gleason score) of 6 or...

**Who might be able to join this trial:** - People who have signed the required consent and privacy authorization forms - Men over 18 years of age - People with a diagnosis of prostate cancer (certain rare types — pure small-cell or pure high-grade neuroendocrine — are not eligible, but prostate cancer that shows some...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy), with a Gleason Score and PSA level recorded - People who have had their prostate surgically removed and whose doctor has recommended radiation treatment to the area where the prostate was,...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer through a tissue biopsy, and whose treatment plan includes a type of internal radiation therapy (called HDR brachytherapy) combined with external beam radiotherapy aimed at curing the cancer. - People who are either fully active...

**Who might be able to join this trial:** - People diagnosed with castration-resistant prostate cancer (a form of prostate cancer that has continued to grow despite hormone-reducing treatment) who have already been through three lines of treatment - People who have given written consent to participate and are able to...

Who might be able to join this trial: - Adults aged 18 or older who are expected to live for at least 12 weeks - People who are generally well enough to carry out daily activities with little or no limitation (as measured by a standard medical scale called ECOG 0–1) - People who have mostly recovered from side effects...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through a biopsy that collected at least 12 tissue samples - People who understand the purpose of the research, agree to take part, and are willing to sign a consent fo...

Who might be able to join this trial: - You have already been told by your doctor that you need radiation therapy as part of your treatment - You are 18 years old or older (there is no maximum age limit) - You are able to understand and make your own decisions about taking part - You are willing and able to give your c...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through a tissue or cell sample - People who have previously had their prostate surgically removed (radical prostatectomy) - People who have previously had radiation t...

Who might be able to join this trial: - You have been diagnosed with prostate cancer and are between 18 and 80 years old - You are currently receiving hormonal treatment for your prostate cancer Who may not be able to join: - Your doctors estimate that you are not expected to live for more than 3 months - Your liver i...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer that has been confirmed by a tissue sample (biopsy), specifically the type called adenocarcinoma - Your prostate cancer is considered "high-risk," meaning at least one of the following applies: the cancer has grown beyond the prost...

**Who might be able to join this trial:** - Men aged 18 or older who previously had radiation treatment (either external beam radiotherapy or brachytherapy) for prostate cancer at certain stages, and whose cancer had not spread to distant parts of the body at the time of that treatment - At least 2 years have passed s...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (confirmed by tissue testing) and have already had their prostate removed as their main treatment, and whose cancer has one or more high-risk features — such as cancer cells found at the edges of the removed tissue, cancer...

Who might be able to join this trial: - People who are over 18 years old - People who have a PSA (prostate-specific antigen) blood test result between 4 and 20 ng/ml, and/or an abnormal digital rectal exam (a physical check of the prostate) - People who are willing to sign a consent form agreeing to take part in the tr...

Who might be able to join this trial: - People who are in good general health and are expected to live more than 10 years - People whose prostate cancer has come back after having their prostate surgically removed (including those who previously had a second surgery to remove the prostate, or who have had radiation the...

Who might be able to join this trial: - People who are 18 years of age or older - People who speak Finnish - People whose doctor suspects prostate cancer, based on a blood test result (PSA level) between 2.5 and 20 ng/ml, an abnormal prostate examination by their referring doctor, or both - People who are able to under...

**Who might be able to join this trial:** - People who have prostate cancer that has continued to grow despite hormone therapy (called castrate refractory prostate cancer) and who have previously been treated with a chemotherapy drug called docetaxel for this stage of the disease - People whose cancer has been confirm...

Who might be able to join this trial: - People who have experienced severe side effects from radiotherapy (radiation treatment) - People who have a type of cancer that is known to be particularly sensitive to radiotherapy Who may not be able to join: - People who are under 21 years old, or who are 99 years old or olde...

**Who might be able to join this trial:** - People who are at least 18 years old - People whose prostate cancer has been confirmed by a tissue sample (biopsy) showing a specific type called adenocarcinoma - People who are reasonably physically active and able to care for themselves — scoring 2 or below on a standard a...

**Who might be able to join this trial:** - People who are neurologically normal — meaning free from unstable neurological or psychiatric conditions, as confirmed by a neurological examination at the start of the trial - People who agree to have unenhanced brain MRI scans (MRI scans without contrast dye) at the start...

Who might be able to join this trial: - The person must be male and aged 21 years or older. - The person must be able to understand and sign a consent form, and be willing to follow the study's requirements. - The person must have a confirmed diagnosis of prostate cancer that falls into one of these categories: high-ri...

**Who might be able to join this trial:** - People who are over 18 years of age and are willing and able to give informed consent to participate. - People who have not previously been diagnosed with prostate cancer, and who are already scheduled to have a prostate biopsy as part of their normal medical care — this inc...

**Who might be able to join this trial:** - People who are male and at least 18 years old - People who have had their prostate removed (radical prostatectomy) as the main treatment for confirmed prostate cancer - People whose PSA levels have risen again after surgery (called biochemical recurrence), meeting specific P...

**Who might be able to join this trial:** - People with a prostate who are 40 years of age or older - People who have a documented inherited gene change (found through genetic testing) in a gene known or suspected to be linked to a higher risk of prostate cancer **Who may not be able to join:** - People who have alrea...

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with prostate cancer confirmed by laboratory tissue analysis - People whose prostate cancer has continued to grow or spread despite having very low testosterone levels (sometimes called castration-resist...

**Who might be able to join this trial:** - You are between 55 and 80 years old - Your doctors expect you to live for more than 10 years - Your prostate cancer aggressiveness score (called a Gleason score) is below 8 if you are under 75, or below 9 if you are between 75 and 80 - Your cancer appears to be contained wit...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a tissue sample (biopsy), with the biopsy taken within 12 months of joining the trial in most cases (confirm with trial site for exceptions) - People whose cancer is...

**Who might be able to join this trial:** **As a Patient Participant:** - You are a man aged 41 or older who is suspected of possibly having prostate cancer - Your PSA blood test result is 4 or higher and your doctor has recommended a prostate biopsy - You are able to attend all required appointments and follow the tr...

**Who might be able to join this trial:** - People who have been diagnosed with metastatic breast cancer that is HER2-negative (a specific tumour type based on lab testing) and whose tumour tests positive for a protein called the androgen receptor (AR) in at least 10% of cells **Who may not be able to join:** - People...

**Who might be able to join this trial:** - Men aged 18 years or older - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) that has been confirmed by a tissue sample, and who need radical radiotherapy (high-dose radiation treatment aimed at curing the cancer) - People whose can...

**Who might be able to join this trial:** - You have signed a consent form agreeing to take part in the study - You are well enough to carry out daily activities with little or no limitation (your doctor rates your general health as reasonably good) - Your prostate cancer has been confirmed by a tissue sample (biopsy)...

Who might be able to join this trial: - People who have signed a consent form agreeing to take part in the study - People whose prostate cancer has been confirmed through a tissue sample (biopsy or similar test) - People with prostate cancer that has spread to a limited number of sites in the body — specifically, no mo...

Who might be able to join this trial: - People who have been diagnosed with a urological cancer, specifically prostate cancer, kidney cancer, bladder cancer, or ureter cancer - People who have had surgery for one of these urological cancers at Severance Hospital, Sinchon, between October 2020 and October 2030 - People...

**Who might be able to join this trial:** - A diagnosis of prostate cancer must be confirmed by a pathologist's report or tissue sample, or by a clinical history consistent with prostate cancer if no tissue sample is available. - The cancer must have spread (metastasised) to at least one site, shown on a bone scan or...

"Who might be able to join this trial: - People who are admitted to hospital for a planned surgical procedure to remove the prostate (called a radical prostatectomy) Who may not be able to join: - People who have declined or refused to give their consent to participate - People who are protected under specific French...

Who might be able to join this trial: - Adults who have had or are currently having their prostate removed using a robot-assisted surgical procedure - People who had normal bladder control (no leaking or incontinence) before their surgery - People (or their legal representative) who understand the research nature of th...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed through a tissue sample analysis - People whose cancer is considered low risk, meaning the cancer is contained within or close to the prostate, has a low grade group score (grad...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a pathology lab within the last 2 years before joining the study — tissue samples must be reviewed by the NCI's Laboratory of Pathology, and a new biopsy may be coll...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer that is confirmed by pathology tests, where the cancer is localised or locally advanced (has not spread far from the prostate). - People who can speak, read, and understand Dutch, French, or English. - People (or their legally a...

Who might be able to join this trial: - People who are older than 40 and younger than 80 years of age - People who have a clinical suspicion or known history of prostate cancer, shown by at least one of the following: a PSA blood test result above 4ng/ml, an abnormal rectal examination finding, or a previous tissue sam...

**Who might be able to join this trial:** - Men aged 18 or older - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma, confirmed by a tissue test) - People who fall into one of two groups: - **Group 1:** People with high-risk prostate cancer (based on a PSA score above 10,...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer that is confirmed by a lab report to be the type called adenocarcinoma (or a mixed type where more than half is adenocarcinoma). - People who have cancer that has spread to the bones, shown by at least one spot on a bone sc...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer that has been confirmed through laboratory testing of tissue samples. - People who have specific gene changes (variants) in certain genes, detected through any type of genetic testing. The genes involved include PIK3, AKT,...

**Who might be able to join this trial:** - You have been diagnosed with high-risk prostate cancer confirmed by a tissue sample (biopsy), meeting at least one of the following: an aggressive cancer grade (Gleason score of 8 or higher); cancer that has spread to the seminal vesicles or nearby structures; a PSA level ab...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a laboratory test on a tissue or cell sample - People whose prostate cancer has spread to other parts of the body, such as soft tissue or bones - People who have ha...

Who might be able to join this trial: - People who are male and aged 18 years or older - People who either have a clinical suspicion of prostate cancer or have had prostate cancer confirmed through a biopsy - People who have had or are currently having a specific type of prostate MRI scan (multi-parametric 3T MRI) at U...

Who might be able to join this trial: - You have had surgery to remove your prostate (radical prostatectomy) to treat prostate cancer, and your PSA levels have risen above 0.2 but below 2.0 ng/mL on two separate measurements, suggesting the cancer may be returning. - A team of medical specialists has reviewed your case...

"Who might be able to join this trial: - People who have been diagnosed with Gleason 7 prostate cancer confirmed by a biopsy, and have been referred to a specialist for treatment - People for whom surgery or radiation therapy is not considered a suitable treatment option at the time of joining the trial - People whose...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer through a specific type of biopsy (using ultrasound guidance with at least 12 tissue samples, plus targeted samples of any areas visible on MRI), with the diagnosis confirmed by the NCI's Pathology Laboratory - People whose...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (specifically the type called adenocarcinoma), confirmed through a tissue sample test - People whose cancer is classified as intermediate or high risk, based on a standard medical guideline called the NCCN definition - Peop...

**Who might be able to join this trial:** - Men aged 18 years or older - People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy) - People whose primary treatment was surgical removal of the prostate (radical prostatectomy) - People whose surgery included a procedure to spare at least...

**Who might be able to join this trial:** - People who are generally well and able to carry out daily activities with little to no limitation (based on a standard health scoring system called ECOG, at level 0 or 1) - People who have been diagnosed with prostate cancer confirmed by tissue testing, specifically a type c...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer, either as a new diagnosis or as a cancer that has come back - People who have had a specific type of imaging scan called a 68Ga-PSMA-11 PET/CT scan to check the stage or restage of their prostate cancer - People whose 68Ga-...

**Who might be able to join this trial:** - People aged 18 years or older - People with a life expectancy of more than 10 years - People who are generally well and able to carry out normal daily activities with little or no limitation (known as WHO performance status 0–1) - People whose prostate cancer was confirmed by...

**Who might be able to join this trial:** - People who have given their written agreement to take part in the study - People aged 18 or older - People whose overall health and ability to carry out daily activities falls within an accepted range, as measured by a standard oncology scale (called ECOG performance status...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (adenocarcinoma type) confirmed by a tissue or cell sample - People whose prostate cancer has spread to other parts of the body (metastatic) and is continuing to grow despite hormone-lowering treatment, shown by rising PSA...

**Who might be able to join this trial:** **Main study group:** - People who have been diagnosed with cancer of the pancreas, prostate, breast, or ovary, confirmed by laboratory testing of a tissue or cell sample. - People whose cancer has a specific genetic change (mutation) in BRCA1, BRCA2, PALB2, or one of a long l...

**Who might be able to join this trial:** - Men between the ages of 20 and 75 - People who have signed a consent form showing they understand what the study involves and are willing to follow its rules and requirements - People who have been diagnosed with a specific type of prostate cancer called adenocarcinoma, conf...

**Who might be able to join this trial:** - People who are over 18 years of age - People who have been diagnosed with prostate cancer - People who are considered safe to exercise and do strength training (those who have had a minor stroke or heart condition in the past will need written approval from their family docto...

**Who might be able to join this trial:** - People who have signed a written consent form before any trial procedures begin. - Men who have been confirmed through laboratory testing (biopsy or cell sample) to have prostate cancer of the adenocarcinoma type. - Men who are 18 years of age or older at the time of signing...

**Who might be able to join this trial:** - People who have given written consent before any study procedures begin (consent can be done remotely) - People who agree to have tissue samples collected at specific points during the study - Males aged 18 years or older - People with prostate cancer that has been confirmed...

**Who might be able to join this trial:** - Adults aged 18 or older who are willing and able to sign a consent form - People with a life expectancy of at least 3 months - People who are willing to have a biopsy (a small tissue sample taken for testing) - People who are well enough to carry out basic daily activities w...

**Who might be able to join this trial:** - People who are male and aged 18 or older - People who have prostate cancer that has spread to other parts of the body (metastatic), is no longer responding to hormone-lowering treatment (castration-resistant), and has been confirmed by a tissue sample (biopsy) - People who h...

**Who might be able to join this trial:** - Men aged 18 or older who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed through a tissue test) - People who have already had, or are scheduled to have, a prostate MRI and/or surgery to remove the prostate as part of their standard c...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer at any stage, confirmed through a tissue biopsy, a PSA blood test result greater than 100 ng/dL, or clear imaging scans showing the disease. - People who currently live in the United States, including Puerto Rico, Guam, American...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a biopsy showing a specific type called adenocarcinoma - People for whom doctors have determined that an extended removal of lymph nodes in the pelvis, combined with robotic surgery to remove the prostate, is the re...

**Who might be able to join this trial:** - You are male - You are older than 18 years of age - You have already been considered a suitable candidate for a specific prostate treatment called TULSA-PRO (confirm with trial site) - You are willing and able to read and sign a consent form agreeing to take part in the study...

**Who might be able to join this trial:** - People who are willing to sign a consent form agreeing to follow the study schedule, attend all visits, and allow their health information to be used for research - Men aged over 18 years - People who have been diagnosed with prostate cancer (adenocarcinoma type) confirmed b...

**Who might be able to join this trial:** - A tissue sample (biopsy) has confirmed a specific type of prostate cancer called acinar adenocarcinoma, and at least 10 biopsy samples were taken - An MRI scan of the prostate has been done to assess the local spread of the cancer - The cancer falls into the "intermediate un...

Who might be able to join this trial: - People who have signed a consent form agreeing to take part in the study - People who are over 18 years of age - People who have previously had their prostate surgically removed and whose laboratory results confirmed prostate adenocarcinoma (a common type of prostate cancer), who...

Who might be able to join this trial: - People who are 18 years of age or older - People who have finished treatment aimed at curing their prostate cancer - People who are receiving prostate cancer survivorship care at one of these specific hospitals: University Health Network (UHN), Trillium Health Partners (THP), Nia...

**Who might be able to join this trial:** - People who have advanced solid tumour cancer of any type (Phase I of the trial) or advanced prostate cancer with a PSA level of at least 0.1 ng/mL (Phase II of the trial) - People whose cancer diagnosis has been confirmed by a pathology report or documented clinical note - P...

**Who might be able to join this trial:** - Men aged 18 or older who have been diagnosed with prostate cancer (confirmed through a tissue sample) and have already had their prostate surgically removed, with a PSA blood test result of 0.1 ng/mL or higher - At least 6 months must have passed between the prostate removal...

Who might be able to join this trial: - People who are male and aged 18 or older - People who have been diagnosed with intermediate or high-risk prostate cancer (confirmed by biopsy), specifically a Gleason grade group of 2 or higher - People whose doctor is considering surgery to remove the prostate (radical prostatec...

Who might be able to join this trial: - People who are willing and able to give written consent to participate - People who have been confirmed through a tissue or cell sample to have prostate adenocarcinoma (a specific type of prostate cancer) - People who have cancer that has spread to other parts of the body, shown...

Who might be able to join this trial: - People who are 21 years of age or older - People who hold board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology - People who currently work in a practice that includes treating prostate cancer patients - People who speak English Who may n...

Who might be able to join this trial: - People who have a confirmed harmful genetic mutation in one of the following genes: BRCA1, BRCA2, MSH2, MSH6, MLH1, PMS2, CHEK2, PALB2, or ATM - People who are over 18 years of age - People who have been diagnosed with prostate cancer and are at a point where imaging to check the...

**Who might be able to join this trial:** - People who are male and aged 18 years or older - People who have prostate cancer with a calculated risk (using a tool called the Briganti nomogram) of cancer spreading to the lymph nodes of between 5% and 20%, and whose pre-surgery scan (called a PSMA PET/CT) shows no signs o...

Who might be able to join this trial: - People who have been confirmed (through a tissue or cell sample) to have prostate cancer, either from a new biopsy or stored tissue. - People aged 18 years or older. - People whose prostate cancer has spread to other parts of the body (metastatic), is no longer responding to horm...

**Who might be able to join this trial:** - A person must be willing and able to give their informed consent to participate. - Male adults between 18 and 75 years of age may be eligible. - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) that has been confirmed by laboratory...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (a specific type called adenocarcinoma) confirmed by a lab test, and you do not have a type called "pure small cell carcinoma" - Your prostate cancer has spread to other parts of the body, is no longer responding to hormone-loweri...

**Who might be able to join this trial:** - Men between the ages of 35 and 74 - People who have not been diagnosed with prostate cancer - People whose general health suggests they are expected to live more than 10 years - People who meet the criteria for one of three groups: - **Group A:** People who have had geneti...

Who might be able to join this trial: - People who are male - People who are aged between 40 and 80 years old - People who are scheduled to have surgery to fully remove the prostate due to prostate cancer that has not spread beyond the prostate - People who can read and speak English or Spanish - People who are willing...

"Who might be able to join this trial: - People who are male and have a confirmed diagnosis of localized prostate cancer (confirmed through a tissue sample/biopsy) - People who are receiving a specific prostate cancer treatment called TPLA (Transperineal Laser Ablation) Who may not be able to join: - People under 18 y...

**Who might be able to join this trial:** - Men aged 18 or older - People who have been confirmed through tissue or cell testing to have prostate adenocarcinoma (a specific type of prostate cancer), but not the small cell type - People whose cancer has spread (metastatic) and continued to grow despite ongoing hormone-...

**Who might be able to join this trial:** - People who had prostate surgery and had a PSA level that was undetectable (below 0.02 ng/ml) within 16 weeks after the operation. - People whose risk of PSA returning within 5 years of surgery is calculated at 25% or higher, based on a specific medical scoring tool called the...

Who might be able to join this trial: - People who are 18 years of age or older - People whose prostate cancer has been confirmed through a tissue sample (biopsy or similar test) - People with localised prostate cancer (cancer that has not spread beyond the prostate) that falls into certain risk categories — low-risk,...

**Who might be able to join this trial:** - People who have given written consent to take part in the trial. - People aged 18 or older. - People with a general health and activity level rated as reasonably functional (scored 0–2 on a standard oncology scale called ECOG — confirm with trial site if unsure what this mea...

**Who might be able to join this trial:** - People who have a confirmed diagnosis of prostate cancer based on a tissue sample (biopsy). - People whose prostate cancer is still responding to hormone therapy that lowers testosterone (known as castration-sensitive prostate cancer). - People with a limited number of areas...

Who might be able to join this trial: - You must be 18 years of age or older - You have been diagnosed with, or previously had, breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, kidney cancer, melanoma, or sarcoma - You are able to understand spoken or written English or Spanish in a...

**Who might be able to join this trial:** - Men aged 50 to 65 who have been clinically diagnosed with low or intermediate risk prostate cancer, where fewer than half of the tissue samples taken from each side of the prostate tested positive for cancer - Men aged over 65 who have been clinically diagnosed with prostate...

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with prostate cancer confirmed through laboratory testing of tissue samples - People who have prostate cancer that has spread to other parts of the body, with at least one affected area visible on standa...

Who might be able to join this trial: - People who are scheduled to have a prostate biopsy to check for prostate cancer - People between the ages of 40 and 69 years old - People who identify as one of four specific ethnic backgrounds: Caucasian, African American, East Asian, or Latino - People whose PSA level (a protei...

**Who might be able to join this trial:** **For people with breast cancer (Arm 1):** - You are a woman aged 18 or older - You are a Brazilian national - Your breast cancer diagnosis has been confirmed by a tissue biopsy and reviewed at Hospital Moinhos de Vento, and your cancer is either HER2-positive (a specific prot...

**Who might be able to join this trial:** - Adults aged 18 or older (children under 18 are not eligible due to how rare this disease is in that age group) - People who have been diagnosed with prostate cancer (either localised or spread to other parts of the body), confirmed through a tissue sample - People who have be...

Who might be able to join this trial: - Men aged over 18 years old. - People with a confirmed diagnosis of prostate adenocarcinoma (a specific type of prostate cancer) proven through tissue testing. - People who have previously had their prostate removed through surgery (radical prostatectomy). - People whose cancer ha...

**Who might be able to join this trial:** - People who are able to give their signed agreement to take part in the study. - People who are male and aged 18 years or older. - People who have been diagnosed with a specific type of prostate cancer (adenocarcinoma) confirmed by a tissue or cell sample, without certain rar...

**Who might be able to join this trial:** - People with prostate cancer that has been confirmed by a tissue sample (biopsy), where the cancer is localised or locally advanced and has not spread to distant parts of the body (specific staging criteria apply — confirm with trial site) - People whose cancer type is adenoc...

**Who might be able to join this trial:** - A diagnosis of prostate cancer (adenocarcinoma type) confirmed by a tissue sample (biopsy). - The original prostate tumour has already been treated and is under control. - A rise in PSA (a prostate-related protein measured in the blood) after surgery to remove the prostate f...

**Who might be able to join this trial:** - Men between 18 and 75 years old - People whose general physical condition is rated at a certain level of functioning (ECOG score of 2 or below — confirm with trial site) - People who have prostate cancer that has stopped responding to hormone-lowering treatments (castration-...

Who might be able to join this trial: - People who have been diagnosed with localised intermediate-risk or high-risk prostate cancer, confirmed through a tissue or cell sample test (intermediate-risk means a Gleason score of 7 and PSA under 10; high-risk means a Gleason score of 8–10, PSA over 10, or cancer that has gr...

Who might be able to join this trial: - People diagnosed with prostate cancer that meets certain severity levels based on how the cancer cells look under a microscope (called a Gleason score), ranging from moderately aggressive to highly aggressive (confirm with trial site for exact score requirements) - People who cur...

Who might be able to join this trial: **Patients (Stage 1):** - Adults aged 18 or older - Able to understand and follow the study procedures for the full duration of the study - Able to understand and willing to sign a written consent form - Able to speak, read, and understand English - Has a confirmed diagnosis of lo...

**Who might be able to join this trial:** - People who have prostate cancer that has been confirmed through laboratory testing of tissue samples - People whose cancer has been determined eligible for a specific treatment called 177Lu-PSMA-617, either through a special access program or as part of an approved trial - P...

**Who might be able to join this trial:** - You have been diagnosed with a blood cancer or a solid tumor (a growth/lump), confirmed by a lab test of a tissue or cell sample - If your type of cancer doesn't usually require a biopsy before surgery to confirm the diagnosis, you may still join, but your eligibility will b...

**Who might be able to join this trial:** - Men who are 45 years of age or older. - People who have been diagnosed with a specific type of prostate cancer called prostate adenocarcinoma. - People whose cancer has been classified at an early stage (T1c or T2a). - People whose cancer has a Gleason score (a measure of ho...

**Who might be able to join this trial:** - You are male and between 45 and 80 years old, with an expected life expectancy of more than 10 years - You have been diagnosed with intermediate-risk prostate cancer, confirmed by a biopsy, falling into specific risk categories (confirm with trial site) - Your cancer has not...

Who might be able to join this trial: - Men aged 18 or older - People where doctors suspect prostate cancer may be present - People with a prostate-specific antigen (PSA) blood test result between 4 and 20 ng/mL - People whose rectal examination results suggest the cancer, if present, appears to be contained within the...

**Who might be able to join this trial:** - People who are 75 years of age or older at the time of signing the consent form - People who are considered healthy or only mildly frail based on a medical check-up and two standard geriatric assessments (called G8 and miniCOG™), which measure overall health and thinking abi...

**Who might be able to join this trial:** - You are a male adult who speaks English - Your doctor believes you are expected to live for more than 10 years - You have had an MRI-guided biopsy of a visible area on your prostate MRI before joining the trial (including additional biopsy samples taken in a standard pattern...

Who might be able to join this trial: - Men who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) confirmed through a prostate biopsy - Men who have had prostate cancer come back in the same area (local recurrence), confirmed by biopsy and standard imaging tests that show the cancer has n...

Who might be able to join this trial: - People who are willing and able to sign and date a consent form agreeing to take part in the study - People who speak English - People who are willing to follow all study procedures and are available for the full duration of the study - People who are 18 years of age or older - A...

**Who might be able to join this trial:** - You have prostate cancer that has stopped responding to hormone therapy and has come back or not responded to at least one anti-androgen treatment and a chemotherapy regimen containing docetaxel. - You have a rare cancer called NUT midline carcinoma that has spread or cannot...

**Who might be able to join this trial:** *Patients:* - Men aged 65 or older - People who have been diagnosed with localised prostate cancer (cancer that has not spread beyond the prostate) - People who have been on an active surveillance program for their prostate cancer for 12 months or more - People who are fluent...

**Who might be able to join this trial:** - Adults aged 18 or older who have had their prostate removed (radical prostatectomy) for prostate cancer, and whose PSA blood test result is 0.2 mcg/L or higher - Adults aged 18 or older who have had radiation therapy, cryotherapy, or brachytherapy for prostate cancer, and wh...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (a specific type called adenocarcinoma) and are scheduled to receive external beam radiation therapy, possibly with or without hormone therapy, at the Wilmot Cancer Institute Department of Radiation Oncology - Your cancer has not...

**Who might be able to join this trial:** - People who have prostate cancer that has stopped responding to hormone therapy (called castration-resistant prostate cancer) and whose PSA levels are rising while taking one of these specific medications: abiraterone, enzalutamide, or darolutamide. - People who have previous...

**Who might be able to join this trial:** - People who have signed an informed consent form agreeing to take part - People whose tumour has been confirmed by laboratory testing of a tissue sample - People who are currently receiving a treatment that works throughout the body (such as chemotherapy or similar) for their...

Who might be able to join this trial: - People who have been diagnosed with, or are suspected to have, breast, brain, or prostate cancer - People who are able to undergo specific PET/CT scans (using 68Ga-RM26-RGD and 18F-FDG, or related imaging agents) within a 2-week period (confirm with trial site for details on whic...

**Who might be able to join this trial:** - Men between the ages of 40 and 65 years - Men who identify as exclusively heterosexual, regardless of race or social background - Men who had their prostate removed (radical prostatectomy, or RP) as treatment for prostate cancer that had not spread to other parts of the body...

**Who might be able to join this trial:** - People who are male and at least 18 years old at the time of signing the consent form - People who have been diagnosed with a type of prostate cancer called adenocarcinoma and/or neuroendocrine carcinoma, confirmed through a tissue sample examination - People whose cancer ha...

**Who might be able to join this trial:** - Male patients who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma), confirmed through a tissue test - People whose prostate cancer is classified as high-risk or very high-risk according to standard medical guidelines (called NCCN guidelines...

**Who might be able to join this trial:** **First stage (initial scan):** - You are 18 years of age or older (there is no upper age limit) - You have a prostate (this includes men born male, or transgender women who have never used hormone therapy to reduce testosterone) - Your doctor has referred you for a prostate M...

Who might be able to join this trial: - People who are starting, or have recently started (within the last 2 weeks), a type of prostate cancer hormone therapy called an androgen receptor axis-targeted therapy (ARAT), or who are switching to a different ARAT because their previous one stopped working or caused side effe...

**Who might be able to join this trial:** **Group 1 – Newly diagnosed prostate cancer (before treatment):** - You have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy) - Your cancer has been classified as medium or high risk based on specific scoring systems used by doctors (Gleason score, can...

**Who might be able to join this trial:** - Men aged 18 or older - Men whose urologist strongly suspects they may have prostate cancer, based on clinical assessment - Men with a BMI greater than 18.5 - Men who have not previously been diagnosed with prostate cancer or received hormonal therapy for it - Men who are abl...

**Who might be able to join this trial:** - People who are 18 years of age or older, of any race or ethnic background - People who have signed a consent form agreeing to take part and follow the study requirements - People who have been confirmed through a tissue test (biopsy) to have prostate cancer that has not spre...

**Who might be able to join this trial:** - People who have been diagnosed with locally returning prostate cancer, confirmed by both tissue biopsy and imaging scans - People who are willing to give their agreement to take part in this clinical trial - People who are able and willing to fill out two health-related quest...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by a tissue sample reviewed by a central laboratory) - People whose prostate cancer is classified as "low risk" — meaning the cancer is at an early, localised stage (T1–T2b)...

**Who might be able to join this trial:** - People who have prostate cancer that has spread to other parts of the body, is no longer responding to hormone-suppressing treatments and/or chemotherapy, and is getting worse over time. - People whose cancer has been confirmed by a specific type of scan (called a 68Ga-PSMA P...

Who might be able to join this trial: - People who are male and aged 18 or older - People with no known history of prostate cancer - People who have not previously had prostate surgery or tissue removal procedures (such as TURP or photovaporization) Who may not be able to join: - People who are unable to have an MRI s...

Who might be able to join this trial: - You have prostate cancer that has spread to other parts of the body, is getting worse, and is no longer responding to hormone therapy. - Your tumors show high levels of a protein called PSMA, confirmed by a special type of scan called a 68Ga-PSMA PET/CT scan. Who may not be able...

**Who might be able to join this trial:** - People who have been diagnosed with low or intermediate risk prostate cancer, confirmed by a tissue sample (biopsy), with the diagnosis verified by the NIH Laboratory of Pathology. - People whose prostate cancer appears in only one single spot, as seen on both MRI and a spec...

**Who might be able to join this trial:** - Men between 18 and 80 years old whose PSA blood test result is above 3 ng/ml and who are being considered for further testing such as an MRI or prostate biopsy - Men who have had a normal prostate exam (done by a doctor feeling the prostate through the rectum) within the pas...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma, confirmed by a tissue test). - People who have at least one sign of cancer that has spread, visible on a CT scan or bone scan. - People whose prostate cancer is getting worse, shown b...

**Who might be able to join this trial:** - You must be over 18 years old. - You must have been diagnosed with prostate cancer (specifically a type called adenocarcinoma), confirmed by a tissue sample (biopsy). - Your cancer must have spread to at least one area in the bones, confirmed by a special bone scan; if only...

**Who might be able to join this trial:** - People aged 18 or older who are able to give written consent and follow the study requirements - People whose cancer can be measured using standard imaging criteria (known as RECIST v1.1) - People with a confirmed diagnosis of small cell lung cancer (SCLC), large cell neuroe...

**Who might be able to join this trial:** - People who are able to understand and are willing to sign a written consent form agreeing to participate - People who have been diagnosed with prostate cancer confirmed by a tissue sample - People whose cancer cells produce a protein called PSMA, confirmed by laboratory test...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (adenocarcinoma type), confirmed by a tissue or cell sample. - Your prostate cancer is classified as low to intermediate risk according to standard cancer guidelines. - You have not received any previous treatment for prostate canc...

**Who might be able to join this trial:** - People aged 18 or older - People who are highly suspected of having prostate cancer based on one or more of the following: a notable rise in their PSA blood test results over time (specific thresholds apply depending on their PSA level); a close family member (parent, siblin...

**Who might be able to join this trial:** - You have prostate cancer that has spread (metastatic) and shows signs of a specific type called neuroendocrine prostate cancer, confirmed by biopsy, blood tests, or certain molecular features - You are 18 years of age or older (there is no upper age limit) - You are well eno...

**Who might be able to join this trial:** - People who are willing and able to give written informed consent to participate - People who are able and willing to attend all required procedures and follow-up visits as set out in the study plan - People who do not have urinary retention (the inability to empty the bladde...

Who might be able to join this trial: - People with known or suspected prostate cancer who have been referred for a prostate MRI scan, to be followed by a type of biopsy that uses MRI imaging as a guide. - People who are willing and able to give written consent to take part before the MRI scan takes place. Who may not...

**Who might be able to join this trial:** - People who have been fully informed about the study and have agreed to take part by signing a consent form, after having enough time to think it over. - Men aged 50 years or older. - People whose PSA blood test result is 15 ng/mL or below. - People who have been diagnosed wi...

**Who might be able to join this trial:** - People who have had prostate cancer come back after previous radiation treatment (such as brachytherapy, external beam radiotherapy, or stereotactic radiotherapy), confirmed by a biopsy - People whose cancer has been assessed by MRI scan (or ultrasound and CT scan if MRI is n...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer confirmed by a prostate biopsy - People whose cancer has been assessed by imaging scans as being contained within the prostate (not spread to other areas) - People whose prostate is larger than 70mL in size, as measured by ultra...

**Who might be able to join this trial:** - A diagnosis of prostate cancer (adenocarcinoma type) confirmed by a tissue or cell sample, without a small cell type. - The cancer must be localised (contained to the prostate area), with a surgeon confirming it can be removed by surgery before joining. - No signs of cancer...

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with prostate cancer for at least one year - People who currently do less than 150 minutes of physical activity per week (which the World Health Organization considers inactive) - People who are covered by a social secu...

**Who might be able to join this trial:** - Adults between 18 and 75 years old (inclusive) - People who have at least one measurable area of cancer that can be tracked during the trial - People in the Phase Ia part (Cohort A): those with an advanced solid tumour that has a specific DNA repair gene change (called an HR...

**Who might be able to join this trial:** - People who have been receiving medication to lower androgen (male hormone) levels as treatment for prostate cancer for more than 26 weeks. - People who are fully active or have only minor limitations in daily physical activity (based on a standard health performance scale sco...

**Who might be able to join this trial:** - People who are male and aged 40 or older - People who have been diagnosed with prostate cancer (adenocarcinoma type), confirmed by a tissue test - People whose lymph nodes were found to be cancer-free, or whose lymph nodes could not be fully assessed, at the time of surgery...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer confirmed by tissue testing, classified as unfavorable intermediate risk or higher risk according to standard medical guidelines (NCCN criteria). - People who have not yet received any definitive treatment for their prostat...

Who might be able to join this trial: - People aged 18 to 85 years old who have been diagnosed with cancer (of any type or stage), confirmed by a medical test such as a biopsy. - Both men and women are eligible. - People who have had a previous cancer diagnosis in the past may also be eligible, as this will be taken in...

**Who might be able to join this trial:** - Men between 50 and 80 years of age - People whose urinary retention (inability to pass urine) has not improved with standard treatments and is caused by a condition called benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland - People...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma) that has spread to other parts of the body, is no longer responding to hormone-lowering treatments, and is getting worse over time. - People who are male and are at least 18 years...

**Who might be able to join this trial:** - People who are 18 years of age or older - People who can understand spoken and written Danish - People who have been referred for an MRI scan (either a full multi-parametric or a bi-parametric type) due to a suspicion of prostate cancer at one of three specific hospitals: Aar...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer confirmed by a tissue biopsy and have had their prostate surgically removed (radical prostatectomy), including those who did not have lymph nodes removed during that surgery. - People whose PSA blood test levels have risen...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer confirmed by a biopsy, specifically a type called adenocarcinoma - People whose cancer is at an early stage (T1c or T2), meaning it is contained within or just around the prostate - People whose cancer has not been found in...

**Who might be able to join this trial:** - People diagnosed with intermediate-risk prostate cancer, either "favorable" or "unfavorable" type, based on specific measurements of cancer stage, cancer grade (Grade Group 2 or 3), PSA level, and how many biopsy samples contained cancer cells. - People whose MRI scan shows...

**Who might be able to join this trial:** - You have been diagnosed with bladder cancer (confirmed by a lab test) and are scheduled to have your bladder surgically removed - Unusual or rare types of bladder cancer are also allowed - Having received treatment (such as chemotherapy) before surgery is allowed - You are ov...

**Who might be able to join this trial:** - Men aged 18 or older who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) that has spread to other parts of the body and is planned to be treated with hormone-blocking therapy (called ADT) - People who have had recent imaging of the body, eithe...

Who might be able to join this trial: - The person must have agreed to take part by signing a consent form before joining the study. - The person must have already received at least one dose of a treatment called AAA617 as part of a separate Novartis-sponsored clinical trial (Phase I through IV) for prostate cancer, an...

**Who might be able to join this trial:** - People who are 18 years of age or older. - People who have given written consent to take part (or whose legal representative has done so on their behalf). - People who agree to allow stored tumour tissue samples from a previous biopsy to be used for research purposes. - Peop...

**Who might be able to join this trial:** - You have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a tissue biopsy. - Your cancer is considered high or very high risk, meaning at least one of the following applies: the tumor has grown into nearby tissue (cT3a–cT4), your...

Who might be able to join this trial: - Men aged 18 or older who are currently being monitored through an Active Surveillance clinic for prostate cancer. - Men who have been diagnosed with prostate cancer and whose medical team has agreed at a specialist group meeting that Active Surveillance (monitoring rather than im...

**Who might be able to join this trial:** - People who have been diagnosed with Stage I to Stage IV prostate cancer that has not spread to the bones (involvement of lymph nodes is allowed, and a previous diagnosis of another cancer is also allowed) - People aged 50 years or older - People who are about to start, or ha...

**Who might be able to join this trial:** - People aged 18 or older - People whose general health and ability to carry out daily activities meets a certain minimum level, as assessed by a standard medical scale called the ECOG Performance Status (score must be below 2) (confirm with trial site) - People who have alrea...

**Who might be able to join this trial:** - People who have signed a written consent form before registering for the trial - People aged 18 years or older - People whose prostate cancer has been confirmed by biopsy or tissue testing to be a type called adenocarcinoma - People with prostate cancer who are currently rece...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy) showing a specific type called adenocarcinoma - Your cancer is classified as either "unfavourable intermediate-risk" or "high-risk" localised prostate cancer (meaning it has not spread beyond...

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with a specific type of prostate cancer called adenocarcinoma that is contained within the prostate (localized) - People whose prostate cancer diagnosis has been confirmed through a biopsy - People whose cancer is clas...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer confirmed by a laboratory test of tissue or cells - People who have measurable signs of the disease visible on a CT scan, MRI, bone scan, or a specialised PET scan (such as Axumin or PSMA-PET) - People whose doctor has plan...

**Who might be able to join this trial:** - People who are able to provide written consent and agree to the release of their personal health information - People who are 40 years of age or older at the time of joining - People who have been diagnosed with prostate cancer and are either currently receiving hormone ther...

**Who might be able to join this trial:** - People with a confirmed diagnosis of a solid tumour cancer that has spread (metastatic) or is locally advanced, as seen on standard imaging scans — the specific cancer type depends on which group (cohort) a person is being considered for: - **Group A:** Any metastatic soli...

**Who might be able to join this trial:** - People diagnosed with prostate cancer that has spread to 1 to 3 areas in the body (with no symptoms from those spread areas), where each affected area is no larger than 5.0 cm or 250 cm³, confirmed by a CT, MRI, or whole-body MRI scan. - People whose PSMA-PET/CT scan (a spec...

**Who might be able to join this trial:** - People who are scheduled to have a laser procedure through a scope to remove excess prostate tissue - People with an enlarged prostate causing bothersome symptoms that have not improved with medication - People with an enlarged prostate that has led to the inability to fully...

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with localised prostate cancer (cancer that has not spread beyond the prostate), confirmed by a tissue sample test - People who are currently on active surveillance (monitoring the cancer rather than treating it immedia...

**Who might be able to join this trial:** - The participant, or their legal representative, must be willing and able to provide written consent before any study procedures begin. - A confirmed diagnosis of prostate adenocarcinoma (a type of prostate cancer) is required, confirmed through tissue testing or a combinatio...

Who might be able to join this trial: - Men attending their first treatment consultation for prostate cancer that has not spread beyond the prostate - Men who were on an active monitoring program for prostate cancer and whose cancer has been found to have progressed, and who are now considering switching to a more acti...

**Who might be able to join this trial:** - People who have been diagnosed with a new (not previously treated) high-risk prostate cancer that has not spread to other parts of the body, confirmed by a tissue sample (biopsy) - People whose cancer meets at least one of the following high-risk features: the tumour has gro...

Who might be able to join this trial: - People whose cancer started in the breast, prostate, lung, or bowel (colorectal), confirmed by a tissue test (biopsy). - People aged 18 or older. - People who have up to five areas where cancer has spread (metastases), located in the bones, lungs, lymph nodes, liver, or brain. -...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (a type called adenocarcinoma), confirmed by a tissue biopsy, across a range of grades from low to high - People who are over 18 years of age - People who have signed a consent form agreeing to take part in the trial - Peop...

"Who might be able to join this trial: - People who have been diagnosed with cancer, or where cancer is suspected but not yet confirmed. - People who have signed a written informed consent form agreeing to take part in the trial. Who may not be able to join: - No exclusion criteria have been listed for this trial (con...

**Who might be able to join this trial:** - People who are willing and able to give written consent to participate. - People aged between 18 and 80 years old, of any gender. - People whose general physical functioning is rated as fully active or restricted only in strenuous activity (as measured by a standard medical s...

**Who might be able to join this trial:** - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a tissue or cell sample from a biopsy - People whose cancer is considered "high-risk" based on at least one of the following: the tumour has grown to a certain size...

**Who might be able to join this trial:** - People who are male and aged 18 or older. - People whose general health and ability to carry out daily activities meets a standard level (rated 0 or 1 on a scale used by doctors to measure this). - People who have been confirmed through lab testing of tissue or cells to have...

**Who might be able to join this trial:** - You are a man aged 18 or older. - You racially identify as Black, or as multiracial including Black. - You have been diagnosed with prostate cancer of any type. - You have low-risk or intermediate-risk prostate cancer AND have a relevant family history — meaning a father, br...

Who might be able to join this trial: - A prostate biopsy is already planned as part of the person's regular medical care. - The person is between 41 and 79 years old. Who may not be able to join: - The person has a known history of bleeding disorders. - The person is currently taking blood-thinning medications (antic...

Who might be able to join this trial: - People who are male and aged 18 or older - People who have been diagnosed with prostate cancer that has not spread beyond the prostate (localised prostate cancer) - People whose case has been reviewed and approved for curative (aimed at curing) treatment by a multidisciplinary me...

**Who might be able to join this trial:** - Men between 40 and 80 years of age - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through a tissue or cell sample - People whose prostate cancer has spread to other parts of the body (metastatic disease) - People...

**Who might be able to join this trial:** - Adults aged 18 or older - People with locally advanced or spreading (metastatic) solid tumour cancers that have been confirmed by laboratory testing, where standard treatments have stopped working, are not available, or caused intolerable side effects - People who have at le...

Who might be able to join this trial: - People who have signed and dated a consent form agreeing to take part. - People who are able and willing to follow all study procedures and are available for the full duration of the study. Who may not be able to join: - People who have ever had a fecal (stool) transplant. - Peo...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer (adenocarcinoma type) confirmed by a tissue sample, where the cancer is at an early-to-locally advanced stage and has not spread to the lymph nodes, bones, or other organs — though a small number of lymph node findings on a...

Who might be able to join this trial: - People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed by a laboratory test on tissue samples, including those whose cancer is being monitored without immediate treatment (called active surveillance) — a biopsy taken within th...

**Who might be able to join this trial:** - You are male and at least 18 years old - You have been diagnosed with low-risk or "favorable intermediate-risk" prostate cancer (a specific, less aggressive form of prostate cancer) - Your cancer is at an early stage, has not spread widely in the prostate, and your PSA (a pro...

**Who might be able to join this trial:** - You are male and at least 18 years old - You are able to sign a consent form on your own, without assistance - You have been diagnosed with prostate cancer (specifically adenocarcinoma) that has not spread to distant parts of the body - Your cancer is considered "high-risk,"...

**Who might be able to join this trial:** - People who are male and aged 18 or older - People who have prostate cancer that has spread to other parts of the body and is no longer responding to hormone-lowering treatment - People who have started taking a medication called olaparib within at least the last two months b...

**Who might be able to join this trial:** *For patients:* - People who have been diagnosed with breast, colorectal, lung, or prostate cancer at age 65 or older, based on medical records or their own report - People who are currently receiving cancer treatment (such as radiation, chemotherapy, immunotherapy, or surgery...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer and need a type of robotic surgery to remove the prostate (called robot-assisted radical prostatectomy) - People who are able to understand the study information and are willing to sign a written consent form agreeing to take pa...

**Who might be able to join this trial:** - People who are willing to give written consent before any study-related procedures begin - People aged 18 or older - People who have been diagnosed with prostate cancer (adenocarcinoma type), confirmed by a tissue sample - People whose prostate cancer has stopped responding...

Who might be able to join this trial: - People who are able to understand and are willing to sign a consent form before any study procedures begin. - People who have been diagnosed with prostate cancer that has spread to other parts of the body (metastatic prostate cancer). - People who are aged 18 or older. - People w...

Who might be able to join this trial: - People aged 18 or older. - People who have previously had their prostate removed (prostatectomy) and/or received radiation treatment to the prostate. - People whose PSA level is rising — specifically at or above 0.2 ng/ml after prostate removal, or at least 2 points above their l...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (confirmed by a tissue sample within the last 180 days) that is considered "high risk" based on at least one of the following: the cancer has spread to certain nearby tissues (stage cT3a or higher), your PSA level is above 20 ng/m...

**Who might be able to join this trial:** - People who have signed a written consent form agreeing to take part in the study - Adults aged 18 or older - People who have prostate cancer that has spread to other parts of the body and is no longer responding to hormone-lowering treatments (known as metastatic castrate-re...

**Who might be able to join this trial:** - Adults who have recently been diagnosed with prostate cancer (a new, first-time diagnosis) - People who attend appointments at either the University Hospital of Guadeloupe or the University Hospital of Rennes - People who live in Guadeloupe, Martinique, the community of Saint...

**Who might be able to join this trial:** - People who have been confirmed by biopsy to have prostate adenocarcinoma (a specific type of prostate cancer) diagnosed within the last 8 months — including people on active surveillance whose cancer has shown signs of progression and who have had a recent biopsy within 8 mo...

**Who might be able to join this trial:** - People who are 18 years of age or older. - People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma), confirmed by a tissue sample. - People whose cancer has spread to other parts of the body, as shown on a CT scan or bone scan. - People...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (specifically adenocarcinoma, confirmed by biopsy) that has not yet been treated - People aged 18 years or older - People whose prostate cancer is classified as low or intermediate risk based on European guidelines, meaning thei...

Who might be able to join this trial: - Men over 18 years old who have prostate cancer and are currently receiving, or are about to receive, at least 6 months of hormone-blocking treatment (called ADT) - People who are able to read and understand English Who may not be able to join: - No specific exclusion criteria ha...

**Who might be able to join this trial:** - You have been diagnosed with prostate cancer (specifically a type called adenocarcinoma) - You are 18 years of age or older - Your prostate cancer has been classified as "unfavorable intermediate risk" based on specific combinations of your PSA level, tumor stage, and biopsy...

Who might be able to join this trial: - Men aged 18 or older, of any racial or ethnic background - Men who have been diagnosed with advanced (spread) prostate cancer and are about to start a new round of treatment (whether it is their first treatment or a later one) - Men who have previously taken part in other clinica...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer (specifically the type called adenocarcinoma), confirmed through a tissue or cell sample. - People who are generally able to carry out daily activities with no or minimal limitations (based on a standard medical scale called ECO...

Who might be able to join this trial: - People who have been diagnosed with prostate cancer at any stage (stage I to IV) - People who are scheduled to have surgery to remove the prostate (any surgical method) - People who have no restrictions on doing at least light physical activity, based on a standard health screeni...

**Who might be able to join this trial:** - People who are 18 years of age or older at the time they sign the consent form - People who are willing and able to give written consent to participate (or have a legal representative do so on their behalf) - People who have been diagnosed with prostate cancer of a specific...

**Who might be able to join this trial:** - Men aged 18 or older - People who have been diagnosed with a specific high-grade prostate cancer (Gleason score of 8 or higher), confirmed by a biopsy showing cancer in at least 3 tissue samples, with at least one sample containing 8 mm or more of high-grade cancer — and the...

Who might be able to join this trial: - People who have signed an informed consent form before any study procedures begin. - People who agree to have tissue samples collected at specific points during the study. - People who agree to a specific laboratory research protocol used at MD Anderson (PA13-0291). - Men aged 18...

**Who might be able to join this trial:** - People who have been diagnosed with prostate cancer confirmed by a laboratory test on tissue or cell samples. - People who are 18 years of age or older. - People who are already planned to receive a standard treatment called 177Lu-Vipivotide Tetraxetan following a specific ty...

**Who might be able to join this trial:** - People who are willing and able to give written consent before any study procedures begin. - People whose prostate cancer meets the US FDA-approved criteria for a treatment called Sipuleucel-T — meaning the cancer causes no symptoms or only mild symptoms, as determined by th...